Combination of Transforming Growth Factor β Antisense and Interleukin-2 Gene Therapy in the Murine Ovarian Teratoma Model

This publication has 19 references indexed in Scilit:

• Modulation of B16 Melanoma Growth and Metastasis by Anti-Transforming Growth Factor ?? Antibody and Interleukin-2
  Journal of Immunotherapy, 1996
• Cytokine Gene Therapy with Interleukin-2-Transduced Fibroblasts: Effects of IL-2 Dose on Anti-Tumor Immunity
  Human Gene Therapy, 1995
• Comparison of Gene Therapy with Interleukin-2 Gene Modified Fibroblasts and Tumor Cells in the Murine CT-26 Model of Colorectal Carcinoma
  Journal of Immunotherapy, 1995
• A novel, sensitive bioassay for transforming growth factor β
  Journal of Immunological Methods, 1993
• The effect of transforming growth factor-β2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma
  Journal of Neurosurgery, 1993
• Induction of Antitumor Immunity by Interleukin-2 Gene-Transduced Mouse Mammary Tumor Cells Versus Transduced Mammary Stromal Fibroblasts
  JNCI Journal of the National Cancer Institute, 1993
• Suppression of high affinity IL-2 receptors on mitogen activated lymphocytes by glioma-derived suppressor factor
  Journal of Neuro-Oncology, 1992
• Generation of lymphokine-activated killer cells in human ovarian carcinoma ascitic fluid: Identification of transforming growth factor-β as a suppressive factor
  Cancer Immunology, Immunotherapy, 1991
• Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response
  Cell, 1990
• Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells
  Cancer Immunology, Immunotherapy, 1988